Wednesday, 10 January 2018
Pfizer ends research for new Alzheimer's Parkinson's drugs
Pfizer ends research for new Alzheimer's Parkinson's drugs Despite investing heavily in trying to cure both diseases, the US drugs giant has now decided to redistribute funding to other areas it deems more likely to produce results. The Daily Mail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment